Sanofi India Share Price

3,120.90-24.60 (-0.79%)

Closed
As On: 12 Jun, 2026, 03:53 PM IST
As On: 12 Jun, 2026, 03:53 PM IST

Sector: Pharmaceuticals
Industry: Pharma - MNC

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	3,184.00
High	3,184.00
Low	3,085.20
Prev Close	3,145.50
Volume	24,030
VWAP(₹)	3,117.38

Share Price	Value
Today/Current/Last	3,120.903,119.95
Previous Day	3,145.503,145.65

Sanofi India Share Recommendations

Mean recosCurrent

BUY

3 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	1	1	1	1
Buy	1	1	1	1
Hold	1	1	1	1
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	3	3	3	3

Recent Recos

Target₹9170
OrganizationICICI Securities
ADD

Target₹9170
OrganizationICICI Securities
HOLD

Target₹6200
OrganizationSharekhan by BNP Paribas
BUY

View all Stock Recommendations

News & Analysis

View all Sanofi India Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	520.80	526.30	468.30	738.90	705.90
Total Income Growth (%)	-1.05	12.39	-36.62	4.67	-2.82
Total Expenses	398.20	413.31	375.80	550.20	516.70
Total Expenses Growth (%)	-3.66	9.98	-31.70	6.48	0.10
EBIT	122.60	112.99	92.50	188.70	189.20
EBIT Growth (%)	8.51	22.15	-50.98	-0.26	-9.99
Profit after Tax (PAT)	91.30	82.19	103.20	136.60	137.70
PAT Growth (%)	11.08	-20.36	-24.45	-0.80	-9.38
EBIT Margin (%)	23.54	21.47	19.75	25.54	26.80
Net Profit Margin (%)	17.53	15.62	22.04	18.49	19.51
Basic EPS (₹)	39.64	35.69	44.81	59.31	59.79

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	476.70	422.60	480.30	415.00	539.20
Total Income Growth (%)	12.80	-12.01	15.73	-23.03	3.53
Total Expenses	338.50	339.00	377.60	320.50	373.60
Total Expenses Growth (%)	-0.15	-10.22	17.82	-14.21	-6.18
EBIT	138.20	83.60	102.70	94.50	165.60
EBIT Growth (%)	65.31	-18.60	8.68	-42.93	35.07
Profit after Tax (PAT)	102.60	61.70	76.00	69.50	119.50
PAT Growth (%)	66.29	-18.82	9.35	-41.84	30.89
EBIT Margin (%)	28.99	19.78	21.38	22.77	30.71
Net Profit Margin (%)	21.52	14.60	15.82	16.75	22.16
Basic EPS (₹)	44.55	26.79	32.99	30.18	51.89

	FY 2024
Total Revenue	2,029.70
Total Revenue Growth (%)	-30.40
Total Expenses	1,560.60
Total Expenses Growth (%)	-25.28
Profit after Tax (PAT)	413.30
PAT Growth (%)	-31.45
Operating Profit Margin (%)	23.37
Net Profit Margin (%)	20.52
Basic EPS (₹)	179.46

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,857.10	2,029.70	2,916.40	2,841.60	3,031.00
Total Revenue Growth (%)	-8.50	-30.40	2.63	-6.25	1.31
Total Expenses	1,385.10	1,560.60	2,088.40	2,109.30	2,262.60
Total Expenses Growth (%)	-11.25	-25.27	-0.99	-6.78	-0.45
Profit after Tax (PAT)	326.70	413.50	603.20	620.60	944.40
PAT Growth (%)	-20.99	-31.45	-2.80	-34.29	97.74
Operating Profit Margin (%)	25.78	23.37	29.10	26.49	26.05
Net Profit Margin (%)	17.78	20.53	21.15	22.40	31.94
Basic EPS (₹)	141.85	179.54	261.91	269.47	410.06

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 10.08% towards employee cost in the year ending Dec 31, 2025. (Source: Standalone Financials)

View Details

Balance Sheet

Annual	FY 2024
Total Assets	1,611.80
Total Assets Growth (%)	-6.01
Total Liabilities	751.20
Total Liabilities Growth (%)	7.38
Total Equity	860.60
Total Equity Growth (%)	-15.23
Current Ratio (x)	1.57
Total Debt to Equity (x)	0.00
Contingent Liabilities	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,254.80	1,611.80	1,715.10	2,071.70	3,061.00
Total Assets Growth (%)	-22.15	-6.02	-17.21	-32.32	4.88
Total Liabilities	505.60	751.20	699.60	795.90	835.40
Total Liabilities Growth (%)	-32.69	7.38	-12.10	-4.73	4.49
Total Equity	749.20	860.60	1,015.50	1,275.80	2,225.60
Total Equity Growth (%)	-12.94	-15.25	-20.40	-42.68	5.03
Current Ratio (x)	1.63	1.53	1.91	2.17	2.85
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	318.60	291.10	297.10	288.80	283.40

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)

View Details

Cash Flows

Annual	FY 2024
Net Cash flow from Operating Activities	461.50
Net Cash used in Investing Activities	-19.20
Net Cash flow from Financing Activities	-392.40
Net Cash Flow	-110.70
Closing Cash & Cash Equivalent	283.80
Closing Cash & Cash Equivalent Growth (%)	-28.06
Total Debt/ CFO (x)	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	438.30	461.70	230.80	398.70	558.80
Net Cash used in Investing Activities	-11.30	-19.20	35.50	650.90	630.80
Net Cash flow from Financing Activities	-447.90	-392.40	-878.30	-1,582.70	-849.00
Net Cash Flow	-20.90	50.10	-612.00	-533.10	340.60
Closing Cash & Cash Equivalent	262.90	283.80	392.90	1,004.90	1,538.00
Closing Cash & Cash Equivalent Growth (%)	-7.36	-27.77	-60.90	-34.66	28.44
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 11.3 cr for investing activities which is an YoY decrease of 41.15%. (Source: Standalone Financials)

View Details

Ratios

Annual	FY 2024
Return on Equity (%)	48.02
Return on Capital Employed (%)	52.72
Return on Assets (%)	25.64
Interest Coverage Ratio (x)	338.20
Asset Turnover Ratio (x)	1.21
Price to Earnings (x)	34.13
Price to Book (x)	16.36
EV/EBITDA (x)	27.17
EBITDA Margin (%)	25.19

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	43.60	48.04	59.39	48.64	42.43
Return on Capital Employed (%)	62.05	53.76	77.99	55.14	33.32
Return on Assets (%)	26.03	25.65	35.16	29.95	30.85
Interest Coverage Ratio (x)	300.59	338.20	511.35	456.41	464.94
Asset Turnover Ratio (x)	1.28	1.21	1.51	1.08	0.99
Price to Earnings (x)	28.82	34.13	30.77	21.69	19.23
Price to Book (x)	12.56	16.36	18.27	10.55	8.16
EV/EBITDA (x)	17.88	27.17	20.88	16.03	19.84
EBITDA Margin (%)	27.81	25.19	30.48	28.00	28.30

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Sanofi India	23.20	8.35	48.02	52.72	25.64	-13.10	23.37	20.52	179.46	1.57	0.00	0.00
Abbott India	35.98	11.70	32.50	41.87	23.87	9.36	30.36	22.39	730.36	2.55	0.00	0.00
GSK Pharma	34.69	15.85	45.68	54.54	23.95	5.71	36.32	27.10	61.15	2.03	0.00	0.00
Pfizer	28.55	22.89	33.24	22.93	27.21	2.32	28.27	40.85	100.38	5.04	0.00	0.00
AstraZeneca	109.98	23.63	21.48	26.00	9.42	30.47	11.51	8.24	75.01	1.77	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

Sanofi Consumer Healthcare India Ltd.
P&G Health

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Sanofi India Stock Performance	-0.79	-3.68	-12.92	-22.48	-51.06	-50.47	-59.94
Abbott India Stock Performance	0.83	-4.51	3.53	-0.06	-16.40	25.75	63.87
GSK Pharma Stock Performance	0.88	-12.22	-12.60	-18.31	-28.91	64.40	45.09
Pfizer Stock Performance	-1.40	-3.67	-6.38	-8.57	-9.43	17.90	-13.84
AstraZeneca Stock Performance	0.26	-1.23	-2.40	-7.20	3.89	157.68	118.60
Add More

Found Peer Comparison useful?

Category	No. of Shares	Percentage	% Change QoQ
Promoters	1,39,09,587	60.40 %	0.00
Pledge	0	0.00 %	0.00
FII	12,99,995	5.65 %	0.09
DII	48,65,206	21.11 %	-0.18
MF	21,32,623	9.26 %	-0.20
Others	29,55,834	12.84 %	0.09

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	60.40	60.40	60.40	60.40
Pledge	0.00	0.00	0.00	0.00
FII	5.65	5.55	5.57	5.60
DII	21.11	21.30	22.28	23.06
Mutual Funds	9.26	9.46	10.42	11.23
Others	12.84	12.75	11.75	10.93

Mutual Funds Ownership

MF Ownership as on 30 April 2026

SBI Contra Direct-G
Equity: Value Oriented
5
- 85.72
  Amount Invested (in Cr.)
- 0.1810202%
  % of AUM
- 0.00
  % Change (MoM basis)
Aditya Birla SL Large Cap Direct-G
Equity: Large Cap
4
- 85.30
  Amount Invested (in Cr.)
- 0.29445859%
  % of AUM
- 0.00
  % Change (MoM basis)
Nippon India Pharma Direct-G
Equity: Sectoral-Pharma
3
- 78.46
  Amount Invested (in Cr.)
- 0.94%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Board Meeting
Quarterly Results
Apr 20, 2026
General Meeting
A.G.M
Apr 02, 2026
Final
480%
Feb 25, 2026

Board Meetings

Announced on	Meeting on
Apr 20, 2026	Apr 28, 2026
Quarterly Results
Feb 19, 2026	Feb 25, 2026
Quarterly Results & Interim Dividend
Oct 23, 2025	Oct 29, 2025
Quarterly Results & Interim Dividend
Jul 18, 2025	Jul 31, 2025
Quarterly Results
May 09, 2025	May 14, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
Feb 25, 2026 Apr 22, 2026 480%
Oct 29, 2025 Nov 07, 2025 750%
Feb 27, 2025 Apr 25, 2025 1170%
Feb 24, 2024 May 03, 2024 1170%
Feb 23, 2024 Mar 07, 2024 500%
Bonus
Announced on Ex-Date
Aug 31, 1994 Sep 23, 1994
Bonus Ratio: 1 share(s) for every 1 shares held
Splits
Announced on Ex-Date
Jan 03, 1996 Nov 18, 1991
Split: Old FV100.0| New FV:10.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Apr 02, 2026 Apr 29, 2026
A.G.M
Nov 18, 2025 Dec 19, 2025
-
Aug 13, 2025 Sep 13, 2025
-
Apr 23, 2025 May 15, 2025
-
Jul 11, 2024 Aug 10, 2024
-

Announced on	Ex-Date	Dividend%
Feb 25, 2026	Apr 22, 2026	480%
Oct 29, 2025	Nov 07, 2025	750%
Feb 27, 2025	Apr 25, 2025	1170%
Feb 24, 2024	May 03, 2024	1170%
Feb 23, 2024	Mar 07, 2024	500%

Announced on	Ex-Date
Aug 31, 1994	Sep 23, 1994
Bonus Ratio: 1 share(s) for every 1 shares held

Announced on	Ex-Date
Jan 03, 1996	Nov 18, 1991
Split: Old FV100.0\| New FV:10.0

Announced on	Meeting on
Apr 02, 2026	Apr 29, 2026
A.G.M
Nov 18, 2025	Dec 19, 2025
-
Aug 13, 2025	Sep 13, 2025
-
Apr 23, 2025	May 15, 2025
-
Jul 11, 2024	Aug 10, 2024
-

About Sanofi India

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 7,187.63 Crore) operating in Pharmaceuticals sector.

Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 476.70 Crore, up 12.80 % from last quarter Total Income of Rs 422.60 Crore and down 11.59 % from last year same quarter Total Income of Rs 539.20 Crore. Company has reported net profit after tax of Rs 102.60 Crore in latest quarter.

The company’s top management includes Mr.Aditya Narayan, Mr.Deepak Arora, Mr.Rachid Ayari, Mr.Mahadev Gawade, Mr.Eric Mansion, Mr.Rodolfo Hrosz, Mr.Vaibhav Karandikar, Mr.Rahul Bhatnagar, Mrs.Usha Thorat, Mr.Haresh Vala. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 31-03-2026, the company has a total of 2.30 Crore shares outstanding.

Sanofi India Share Price Today is Rs. 3120.90. On previous day, the Sanofi India Share Price (NSE) closed at Rs. 3176.6, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 60.4% of the stake in Sanofi India shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Sanofi India stocks was 5.65% as compared to 5.55% in Dec 2025 with increase of 0.1%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 21.12% as compared to 21.3% in Dec 2025 with decrease of 0.18%. Out of the total DII holdings in Sanofi India shares 9.26% was held by mutual funds. The rest including public held is 12.83%. Sanofi India stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Sanofi India Dividend: Ever since 1956, Sanofi India dividends has been paid out around 61 times. As on 12 Jun, 2026, 03:53 PM IST, The overall dividend yield for Sanofi India stands at 3.87%. The last dividend paid was on April 22, 2026 (Rs. 48.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 134.52.

Sanofi India Bonus: The most recent bonus issue had been in year September 23, 1994 around 31 years ago at 1 : 1 ratio. The first bonus issue was announced in Aug 1994.

Stock Forecast:
After showing 476.7 Cr. of sales and 12.8% of quarterly net profit, there have been multiple ups and downs in the Sanofi India stock prices in the past few weeks. For example, Sanofi India stock price on 4th of June 2026 was around Rs. 3179.5. Sanofi India share price now stands at an average of Rs. 3120.90. Judging by last week's performance, stock is in down trend.

Sanofi India has a median target price of Rs. 4656.0 in 12 months by 3 analysts. They have provided a high estimate of Rs. 5550.0 and low estimate of Rs. 3931.0 for Sanofi India share.

Historical Prices and Performance:
Sanofi India, incorporated in 1956 is a Mid Cap company (with a market cap of Rs. 7244.28) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Sanofi India stock was 43.6%, 48.02%, 59.38%, 48.64% and 42.43% respectively.
The Sanofi India share gave a 3 year return of -54.9% as compared to Nifty 50 which gave a return of 24.77%.
Sanofi India announced 480.0% final dividend on April 22, 2026.

Key Metrics:
PE Ratio of Sanofi India is 23.61
Prices/Sales Ratio of Sanofi India is 6.99
Price/Book Ratio of Sanofi India is 8.5

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Sanofi India, major competitors and peers include Abbott India, GSK Pharma, Pfizer and AstraZeneca. As of Dec 2025, the dividend yield of Sanofi India stands at 3.87% while Abbott India, GSK Pharma, Pfizer and AstraZeneca stand at 2.52%, 2.71%, 1.64% and 0.39% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 23.61 and 8.5 respectively.

Leadership of Sanofi India :
Haresh Vala is Co. Secretary & Compl. Officer
Aditya Narayan is Chairman & Ind.Director
Deepak Arora is Managing Director
Rodolfo Hrosz is Non Executive Director
Vaibhav Karandikar is Non Executive Director
Eric Mansion is Non Executive Director
Rachid Ayari is WholeTime Director & CFO
Mahadev Gawade is Whole Time Director
Usha Thorat is Independent Director
Rahul Bhatnagar is Independent Director

Industry

Pharma - MNC

Key Indices Listed On

BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty Smallcap 500

Address

Sanofi House,CTS No. 117-B,Mumbai, Maharashtra - 400072

Contact

igrc.sil@sanofi.com

http://www.sanofiindialtd.com

PE Ratio(x)	23.20
EPS - TTM(₹)	134.52
MCap(₹ Cr.)	7,187.63
MCap Rank	55
PB Ratio(x)	8.50
Div Yield(%)	3.94
Face Value(₹)	10.00
52W High(₹)	6,410.00
52W Low(₹)	3,054.00
MCap/Sales	6.99
Beta(1 Month)	0.46
BV/Share(₹)	373.68

PE Ratio(x)	23.19
EPS - TTM(₹)	134.52
MCap(₹ Cr.)	7,185.44
MCap Rank	55
PB Ratio(x)	8.41
Div Yield(%)	3.94
Face Value(₹)	10.00
52W High(₹)	6,399.95
52W Low(₹)	3,057.60
MCap/Sales	6.99
Beta(1 Month)	0.54
BV/Share(₹)	373.68

1 Day	-0.79%
1 Month	-3.55%
3 Months	-13.19%
1 Year	-49.44%
3 Years	-54.36%
5 Years	-59.55%

1 Day	-0.81%
1 Month	-3.53%
3 Months	-13.17%
1 Year	-49.34%
3 Years	-54.35%
5 Years	-59.57%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Sanofi India Share Price

Key Metrics